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Several technologies are in use for the management o f insect pests, wherein, 
different protocols and guidelines are being followed for testing their bioefficacy 
and biosafety. Therefore, it is important to have a comparative assessment 
o f bioefficacy and biosafety o f different pest management technologies viz. 
synthetic pesticides, biopesticides, natural plant products, natural enemies, 
and genetically modified organisms (GMOs) to the nontarget organisms in 
the environment. Toxicology and biosafety data should be generated on 
prescribed animals as per the national and international protocols 
recommended by the government agencies, FAO, WHO, OECD, and EPA. 
Natural plant products, natural enemies, and insect-resistant crops developed 
through conventional and genetic engineering approaches should be viewed 
differently and safety requirements simplified and relaxed as appropriate, 
as compared to the synthetic insecticides. Generation o f data on bioefficacy 
should not only be done in micro-plots at the research stations, but also on 
the farm ers’ fields across a range o f  environments. Eco-safety data 
requirements and test protocols need a holistic review to ensure that priority 
risks are addressed and tests are focused on realistic exposure regimes.
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• Maximum permissible levels o f chemical contaminants (synthetic 
pesticides/b iochem ica l pesticides, m ycotoxins, heavy  m etals, 
pathogens, etc.).
• Quality control for ensuring quality.
• Application o f hazard analysis and critical control point (HACCP), and 
good hygienic practices during production and processing.
• Information on manufacture and process details.
• Information about raw materials, solvents used for extraction, and 
reagents entering the manufacturing process.
• Standardized criteria (chemical consumption).
• Stability o f  botanicals/botanical preparations (residual and shelf-life 
time).
Table 2: Information on phytotoxicity, metabolism and persistence in the 
environment.
Bioefficacy parameter Insecti­
cides
Botanical
pesticides
Biopes­
ticides
Effectiveness V V V
Phytotoxicity V V V
Effects on parasites and predators yl V V
Translocation in plants V X
Metabolism/degradation in plants, soil, and water V V V
Persistence in soil/water/plant V V V
Compatibility V V V
Residues in plant/soil V V V
Residue tolerance limits V V V
Cost: benefit ratio V V V
Registration status in other countries V V ■V
Bioefficacy parameter Natural
enemies
Insect resis­
tant transge 
nic crops
Insect resis­
tant 
cultivars
Effectiveness V V V
Phytotoxicity X X X
Effects on parasites and predators Indigenous
fauna
V X
Translocation in plants X X X
Metabolism/degradation in plants, soil, and water x V X
Persistence in soil/water/plant X V X
Compatibility V V X
Residues in plant/soil X V X
Residue tolerance limits X Transgene
product
X
Cost: benefit ratio V V V
Registration status in other countries V V V
Modified from data requirements by the Central Insecticide Board for Synthetic Pesticides 
(http://cibrc.nic.in). V = required, x = Not applicable.
Information on ecological testing is used by the Registration Committees 
to determine potential hazards, if  any, to human health and nontarget 
organisms such as birds, livestock, fish, honeybees, etc. in the environment. 
Potential adverse ecological effects are assessed from the data generated in 
a tiered fashion, beginning with less expensive acute toxicity tests on a few 
representative organisms and progressing through more expensive chronic 
toxicity tests to a final tier o f simulated and/or actual field tests. The 
minimum data on ecological-effects required to support the registration of 
an outdoor-use include toxicity tests on nontarget organisms such as: i) 
birds, ii) fish, iii) honeybees, iv) livestock, v) spray operators, and vi) 
industrial workers. Information on use pattern, environmental degradation, 
and mammalian toxicity is desirable to determine if  additional testing is 
required to assess the risk further. Such information on risks and fate o f 
the chemical/organism in the environment assists in deciding the toxicity 
status o f  the product.
The initial toxicity data are required to estimate acute toxicity (LC50, 
EC50 and LD50) o f  the active ingredient to aquatic and terrestrial organisms 
(rat/mice/fish). Further studies may be required for evaluation o f toxicity 
to livestock, and the effects o f a pesticide on parasites and predators. In 
case o f botanical pesticides, information on acute toxicity, neuro-behavioral 
and reproductive effects, carcinogenicity, mutagenicity, and effects on spray 
operators is also necessary for sale and field application. The second tier 
data on toxicity to birds, honeybee, fish, livestock and spray operators are 
however not required in special cases due to proven safety o f  the natural 
molecule. Information on phytotoxicity is important for both natural and 
synthetic pesticides, as the effectiveness depends upon the inherent toxicity 
to the host plant. Normally, the effects o f natural pesticides on parasites 
and predators are not essential, presuming that natural products are 
h arm less. H ow ever, these products m ust be eva lu a ted  on a few 
representative species to determine their safety to the natural enemies 
and other nontarget arthropods. In the case o f  neem-based pesticides, long­
term toxicity data on neuro-behavior toxicity, mutagenicity, carcinogenicity, 
effect on reproduction, and health records o f workers are also required 
(Shetty 2004).
Studies on the fate o f  pesticides in the environment are a pre-requisite, 
w hereas in the case o f  natural products (botan ical pesticides and 
biopesticides), such studies may not be required as they degrade in the 
environment faster than the synthetic molecules. However, such decisions 
must be based on the known facts. Data related to fate in environment 
includes translocation, metabolism and persistence in soil, plant, and water 
bodies. Information on the primary/secondary metabolites, degradation/ 
metabolic pathway(s), half-life, persistence in different environmental 
segments (soil, sediment, water, and air), dissipation, mobility and likely 
concentrations in the environment, and bioaccumulation is helpful to 
establish persistence o f the pesticide. Aerobic and anaerobic metabolism
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tests are perform ed in soil and w ater. E nvironm ental transport is 
determined through leaching, adsorption/desorption and volatilization 
studies. Leaching and adsorption/desorption data are important as it depends 
on the chemistry o f the active ingredient as well as the formulants used in 
the final product, use patterns, and other pertinent factors. These tests are 
considered basic to an understanding o f likely field-dissipation routes under 
actual-use conditions at maximum label rates. Harvest time residue of a 
particular compound in the soil as well as in the produce needs to be 
estimated. Based on these data, maximum residual limit (MRL) and waiting 
period are estimated. Furthermore, for synthetic m olecules, effluent 
treatment procedures need to be mentioned for environmental safety 
(Kapustka et al. 1996). For botanical pesticides, no such data are required 
for registration, as there are no reports o f  their persistence in the 
environment (Waage 2001). Test reports about the quality o f the product 
should be obtained from a laboratory with ISO 9000. The applicant should 
also provide sample along-with standard technical sample from  the 
principals/ authorized dealers for chemical verification. In case o f technical 
grade pesticides, samples o f standard impurities are also to be provided for 
chemical verification. Methodology for residue estimation should also be 
provided along with information on carcinogenicity and genotoxicity.
Biosafety o f biopesticides
The W orld  H ea lth  O rgan ization  (W H O ) m em orandum  provides 
recom m ended safety tests for application to biological agents under 
consideration for widespread use in pest control (WHO 1979). The basic 
principles utilized in developing these recommendations are: i) the hazards 
presented by microbial pesticides are inherently different from those 
associated with the use o f  chemical pesticides, and the tests used to 
determine potential hazard to humans should be reflected, ii) a high 
proportion o f negative results is likely, iii) tiered testing systems should be 
used, negative data obtained at any level would obviate the need for further 
testing, and iv) the primary tier testing protocols should be designed to 
expose test animals to the microbial agents under conditions that provide 
maximum opportunity for expression o f any adverse effects (Burges et al. 
1981).
Information on identity, host range, mode o f action in natural hosts, 
and optimum and maximum temperatures for growth o f the organism should 
be elicited, especially in relation to hazard assessment early in the research 
phase. The suggested tests for bacteria and fungi are given in Fig. 1 (Chapter 
V). These tests are arranged in three tiers, any o f which can lead directly to 
an assessment o f the potential hazard. If all the tests in the first tier produce 
negative results, the organism can be considered safe for use as directed, 
without further experimentation. Information on the safety o f  material 
added subsequently to improve adherence and longevity need to be obtained
separately. The biosafety tests include: i) oral intraperitoneal, respiratory 
exposure, eye and dermal exposure, allergenicity, hypersensitivity and 
mutagenicity tests, and tier 2 and 3 tests. The emphasis should be on 
infectivity rather than toxicity, since spores o f protozoa and viruses are not 
known to be associated with toxins. It is therefore necessary to use 
mammalian tissue cultures in Tier 1, as they provide a sensitive test for 
infectivity. In addition, they provide material with which the tests through 
incorporation o f  viral DNA into the host genome need to be conducted. 
M icrosporidial insecticides may be related to a natural microsporidan 
pathogen o f mammals, which is known to attack the nervous tissue. 
Therefore, the intracranial route should be included in the Tier 1 tests 
with insect microsporida.
Biosafety requirements for natural enemies
The Food and Agriculture Organization (FAO) code o f conduct is being used 
to address the application o f  biocontrol measures prior to import and export 
o f  the natural enemies, which also provides internationally accepted 
procedures. The International Standards for Phytosanitary Measures (ISPM 
3; Code o f conduct for the import and release o f exotic biological control 
agents) has been further revised and published by the Secretariat o f the 
International Plant Protection Convention (IPCC in 2005 as “Guidelines for 
the export, shipment, import and release o f  biocontrol agents and other 
beneficial organisms”). The developing countries that have recently started 
the use o f biocontrol agents or those with an opportunity to use biological 
control have benefited most from ISPM 3. This is expected to become the 
standard for all biocontrol introductions worldwide. ISPM 3 has ensured 
that environmental issues are addressed properly, and would provide a 
mechanism for formalizing good practice and setting standards for decision 
making within an internationally recognized framework.
The environmental impact o f  biocontrol agents can be defined as any 
measurable effect on a nontarget species resulting from the introduction o f 
an exotic organism. The results could be complex, with effects on several 
species in the food-web spanning three trophic levels. An indirect effect 
could be increased competition for host or prey with the native natural 
enemies or habitat modification (van Lenteren 1997). Till now, very few 
problems have been reported concerning negative effects o f releases of 
arthropods for controlling arthropods, despite more than 5,000 introductions 
in at least 196 countries or islands. Though ISPM 3 gives the regulations to 
be followed for release o f biological control agents, it does not provide 
methods for assessment o f  environmental risks, van Lenteren et al. (2006) 
and Bigler et al. (2006) have tried to develop comprehensive and quick scan 
environmental risk assessment methods for biological control agents, van 
Lenteren et al. (2003) listed five risk factors: host range, establishment, 
dispersal, direct nontarget effects, and indirect nontarget effects. The risk 
assessment involves three phases:
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• Risk identification and evaluation.
• Risk management, including risk mitigation or reduction.
• Risk/benefit analysis o f the proposed release.
It has been recommended to avoid using generalists or adventive species, 
expand host-specificity testing, incorporate more ecological information, consider 
ecological risk in target selection, prioritize agents, and pursue genetic data on 
adaptation with which we can further increase the safety o f biocontrol agents.
Biosafety assessment o f entomopathogenic nematodes
Studies on the safety o f entomopathogenic nematodes (EPN) to nontarget 
organisms have been reviewed by Akhurst and Smith (2002). Available evidence 
clearly indicates that EPN are safe biocontrol agents, which are more specific, 
and pose lower risk to the environment than the chemical insecticides. Since 
the first use o f EPN for insect control as early as in 1935 (Glaser and Farrel 
1935), no environmental or health hazard associated with their use has been 
reported, despite their widespread use particularly over the past two decades. 
In general, the protocols followed for the use o f natural enemies can be adapted 
for the production and release o f entomopathogenic nematodes.
E nviron m en ta l risks associa ted  w ith  in sect-resistan t 
cultivars
Organization for Economic Cooperation and Development in 1993 made first 
attempt to consider environmental safety issues associated with growing or 
using a particular plant as food, fiber, fuel, or for any other purpose (OECD 
1993). Gene transfer, weediness, trait effects, genetic and phenotypic 
variability, expression o f genetic material from pathogens, and worker safety 
are the six important issues that need to be addressed for environmental 
safety. Environment Protection Agency (EPA) in 1994 proposed that traits 
intended for pest control be subjected to regulation under the Federal 
Insecticide, Fungicide and Rodenticide Act (FIFRA) as plant pesticides. The 
regulation has still not been approved, as a consortium of 11 scientific societies 
challenged the concept that the traits used in plants for defense against pests 
cannot be equated with pesticides applied to plants. Some plant defense 
chemicals also affect the food quality. Gossypol and related compounds are 
toxic to non-ruminant vertebrates (Lambou et al. 1966). Rutin, chloroginic 
acid, tomatine, and phenols may have toxic effects on humans, and some of 
these compounds may also have carcinogenic and mutagenic effects.
One o f  the major environmental impacts o f deployment o f insect-resistant 
genotypes has been development o f virulent insect populations overcoming 
host resistance. Selection o f inseect populations for virulence limits the utility 
o f resistance genes. Nearly 86 biotypes in 22 insect species feeding on nine 
crops have been reported (Smith 2005). To cope with the problem of emerging 
biotypes, the foremost requirement is systematic surveillance and monitoring
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o f biotypes, which is helpful in breeding pest-resistant cultivars. There is a 
need for developing short- and long-term strategies to breed for insect 
resistance, with a focus to broaden the genetic basis o f resistance, involving 
both major and minor genes. This includes identification o f donors o f new 
resistance genes, sequential release of varieties with major genes, pyramiding 
of major genes, development o f multilines and synthetics through horizontal 
resistance, wide hybridization, and gene rotation.
Biosafety assessment o f transgenic crops
No transgenic crop can be used commercially until its agronomic superiority 
is assessed vis-a-vis compared with traditional best checks in farmers’ fields. 
A  series o f open field trials are mandatory to meet regulatory requirements 
for agronomic performance, once safety and efficacy has been established. 
The open field trials are divided into: confined field trials, multi-location 
research trials, and large-scale field trials. These trials are spread over a 
period o f 5 to 6 years. The initial information is generated under laboratory 
and greenhouse conditions with the permission o f the Institutional Biosafety 
Committee (IBSC). The environmental impact studies are undertaken as 
per the norms stipulated by the Genetic Engineering Approval Committee 
(GEAC) o f  the Department o f Biotechnology (DBT) by different public sector 
institutions and accredited private laboratories (DBT 2007). These include 
pollen flow, germination, aggressiveness and weediness, soil analysis 
covering effect on soil micro-biota and the presence o f  transgene protein in 
soil, effects on nontarget and beneficial insects, and baseline susceptibility 
studies (Table 5).
Table 5: Assessment of environmental biosafety/impact of genetically 
engineered crops.
Test Remarks
Greenhouse
evaluation
Pollen flow and gene 
transfer
Germination, aggres­
siveness, weediness 
Effects o f rhizoshpere
Impact on nontarget 
organisms
Baseline susceptibility
The greenhouse and confined field trials are conducted for 
selection of elite events and to assess preliminary biosafety, food 
safety and environmental effects.
The pollen flow studies are carried out to estimate outcrossing 
frequencies, determine possibility of gene transfer into closely 
related species, and assess weediness characteristics of GM crops. 
These studies are undertaken to confirm that the introduced 
gene will not confer any fitness disadvantage to the wild species. 
These studies include effects o f expressed protein on soil 
microflora and invertebrates. These studies cover different agro- 
climatic zones as per protocols approved by the regulatory 
authorities.
Given the importance of beneficial insects, it is mandatory to 
conduct studies on the effect of GM crops on nontarget organisms. 
Data on baseline susceptibility should be generated as a part of 
post-release requirements to assess development of resistance 
following large-scale release of the transgenic crop.
Source: ISAAA (2009).
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The regulatory authorities have specified a number o f defined safety 
tests to determine potential impact o f  genetically engineered crops on 
human and animal health based on the modification o f the proteins in the 
plant or based on the use o f transgene {e.g. Bt protein). The transgenic 
crop under evaluation is subjected to toxicity, allergenicity and feeding 
tests, which includes acute, sub-chronic and chronic testing. More 
precisely, the human/animal health safety testing is done on fish, chicken, 
rabbit, rats, goats and cows, and on other model animals as recommended 
on a case-by-case basis. The transgenic crops are also tested for toxicity to 
ascertain that it contains no new allergenic com pounds and is non- 
allergenic. The foliage and fruit feeding studies are undertaken in goat 
and cow. Other studies include protein expression and quantification, 
substantial equivalence, and protein estim ation in cooked food. The 
toxicity, allergenicity, and food and feed safety evaluation tests are listed 
below.
• Acute oral toxicity studies in Sprague dawley rats.
• Mucous membrane irritation test in female rabbit.
• Primary skin irritation test in rabbit.
• Substantial equivalence (compositional analysis) studies.
• Sub-chronic oral toxicity study in Sprague dawley rats.
• Assessment o f allergenicity o f protein extracts using brown Norway 
rats.
• Dietary feed tests on common carp for evaluating growth performances.
• Food cooking and protein estimation in cooked food.
• Sub-chronic feeding studies using New Zealand white rabbit.
• Effect on performance and health o f broiler chickens.
• Sub-chronic feeding studies in goats.
• Feeding studies in lactating crossbred dairy cows.
• Protein expression studies.
E f f e c t s  o f  V a r io u s  C r o p  P r o t e c t io n  T e c h n o l o g ie s  o n  H u m a n  
H e a l t h
Human health effects are caused through: i) skin contact, ii) inhalation, 
and 3) ingestion through food or in water. Industry and farm workers are 
exposed to inhalation and skin contact during preparation and application. 
H ow ever, for the m ajority  o f  pop u lation , the p r in cip a l source o f  
contamination is through food and water. The harmful effects o f  pest control 
technologies on human beings are:
• Death.
• Cancers, tumors, and lesions.
• Reproductive inhibition.
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• Disruption o f immune and endocrine system.
• Cellular and DNA damage.
• Teratogenic effects (physical deformities).
• Poor health marked by low red to white blood corpuscles ratio.
• Intergenerational effects that are more pronounced in subsequent 
generations.
Many o f these may not be due to direct effects, but associated with a 
com bination o f  environm ental stresses such as eutrophication  and 
pathogenesis (Baker and Wilkinson 1990; Margni et al. 2002). Although 
several documents on safety assessment o f pesticides as ingredients in food 
and food supplements are available, the relevant legislative framework and 
guidance for risk assessment have not yet been established. For transgenic 
crops, the standard tests for biosafety o f transgenic crops for human health 
include: i) mammalian toxicity, ii) digestibility, iii) allergenicity and homology 
with known food allergens and toxins, iv) com positional analysis, v) 
nutritional assessment (concentrations and effects on bioavailability), and 
vi) unexpected or unanticipated effects. A comprehensive evaluation o f the 
new technology in terms of its environmental impact that contributes towards 
sustainable agriculture forms an integral part o f India’s regulatory system 
for the approval o f transgenic crops.
C o n c l u s io n s
There is an urgent need for standardization and harmonization o f protocols 
for assessm ent o f  bioefficacy and biosafety o f  synthetic pesticides, 
biopesticides, natural plant products, natural enemies, and GMOs to the 
nontarget organisms in the environment. Toxicology and biosafety data 
should be generated on prescribed animals as per the national and 
international protocols recommended by the government agencies, FAO, 
WHO, OECD, and EPA. Regulatory measures need to be reinforced to 
prevent use o f spurious pesticides, and check adulteration o f botanical and 
microbial products with undesirable materials. Plant products intended as 
pesticides should be devoid o f undesirable substances toxic to humans and 
domestic animals. Unintended pathogenicity and long-term impact o f 
microbials towards non-pathogens and other nontarget organisms should 
also be studied properly. Natural plant products, natural enemies, and insect- 
resistant crops developed through conventional and genetic engineering 
approaches should be viewed differently and safety requirements simplified, 
and relaxed as appropriate as compared to the synthetic insecticides.
Expert groups o f researchers, academia, practitioners, and regulatory 
bodies should be established at the national and international levels to 
prevent injudicious use o f pest control technologies and monitor nontarget 
effects on the environment. Generation o f data on bioefficacy should not 
only be done in micro-plots at the research stations, but also on the farmers’
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fields across a range o f environments. There is a need to develop a database 
on protocols and effects o f  pest m anagem ent tech n olog ies on the 
environment to make informed decisions about the possible and safer 
interventions for pest management. Eco-safety data requirements and test 
protocols need a holistic review to ensure that priority risks are addressed 
and tests are focused on realistic exposure regimes.
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